$PBHC

Pathfinder Bancorp, Inc. (PBHC): Results of Operations and Financial Condition

Pathfinder Bancorp, Inc. (PBHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pbhc-ex99_1.htm EX-99.1 EX-99.1 Investor/Media Contacts James A. Dowd, President, CEO Justin K. Bigham, Executive Vice President, CFO Telephone: (315) 343-0057 Pathfinder Bancorp, Inc. Announces Financial Results for the Second Quarter of 2026 Pathfinder grew earnings t

Original reporting
Published Jul 30, 2026, 8:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PBHC
Bullish
medium confidence
Mentioned
$PBHC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PBHCBullishMed
01

Why it matters

The most tradable elements are the reported earnings per share, net interest income and margin, deposit and loan balances, and the allowance for credit losses versus charge-offs.

02

Market read

Provides fresh, company-specific quarterly datapoints for small-bank credit and NII performance, which can move valuation multiples and near-term expectations.

03

What to watch

Commercial loan mix and nonperforming transfers drove yield changes; traders should watch whether those dynamics reverse in subsequent quarters and whether charge-offs persist despite reserve absorption.

Relevance 7/10Novelty 6/10Timing: after-hours filing for Q2 2026 results (filed July 30, 2026)

Background

This is an SEC 8-K (Item 2.02) with Q2 2026 financial results and management commentary on credit costs and net interest income drivers.

Company-level read

Ticker impact

$PBHCBullishMedium confidence
Context

Pathfinder Bancorp reported Q2 2026 net income of $0.42 per diluted share, with ACL at $26.9M and net interest income rising to $10.5M.

Expected impact

Near-term bias modestly positive if investors focus on earnings improvement and stable credit costs; downside risk if loan/deposit trends or reserve adequacy concerns re-emerge.

Evidence & confidence

The filing provides concrete datapoints: earnings up sequentially, NII and NIM slightly down vs year-ago, deposits down sequentially, and ACL coverage easing from 3.24% to 3.03% while net charge-offs remain elevated versus Q1.

Market effects

Adds another datapoint on small-bank NII drivers via AFS securities deployment and ongoing credit normalization.

Limited to the company’s footprint, but can influence sentiment toward regional bank credit quality and funding stability.

Low; not a cross-market macro or systemic banking event.

Counterpoint

The sequential earnings improvement may be more balance-sheet management than underlying loan growth, with deposits declining and ACL ratio still above the prior-year level.

Key entities

  • Pathfinder Bancorp, Inc.

    NASDAQ-listed holding company reporting Q2 2026 results, credit metrics, and NII drivers.

  • Pathfinder Bank

    Operating bank referenced in the earnings release context.

Related articles

$PBHCMed

Prosperity Bancshares, Inc. Q2 2026 Earnings Call Summary

Strategic Integration and Performance Drivers Management successfully closed the Stellar Bancorp merger on July 1, 2026, adding 52 banking offices and significantly expanding the Houston and East Texas footprint. Core net income growth of 20.4% year-over-year was driven by the repricing of assets and the successful inclusion of American Bank and Texas Partners Bank results.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.